Validation of the cantharidin-induced skin blister as an in vivo model of inflammation

British Journal of Clinical Pharmacology

Volumn 72, Issue 6, 2011, Pages 912-920

  Dinh, Phong Huy Duc ^a,c   Corraza, Francis ^b   Mestdagh, Kristel ^a   Kassengera, Zaina ^b   Doyen, Virginie ^a   Michel, Olivier ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c PHAM NGOC THACH UNIVERSITY OF MEDICINE   (Viet Nam)

Author keywords

Anti TNF; Blister; Cantharidin; Inflammation; Steroids

Indexed keywords

ADALIMUMAB; CANTHARIDIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; BLISTER; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL COUNT; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; BLISTER; CANTHARIDIN; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; IRRITANTS; MALE; METHYLPREDNISOLONE; MODELS, BIOLOGICAL; NEUTROPHILS; REPRODUCIBILITY OF RESULTS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80855144256     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.04020.x     Document Type: Article

References (18)

1. Groneberg DA, Chung KF. Models of chronic obstructive pulmonary disease. Respir Res 2004; 5: 18-34.
2. Fiuza C, Suffredini AF. Human models of innate immunity: local and systemic inflammatory responses. J Endotoxin Res 2001; 7: 385-8.
3. Day RM, Harbord M, Forbes A, Segal AW. Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. J Immunol Methods 2001; 257: 213-20.
4. Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T, Newson J, Bellingan G, Gilroy DW. Effects of low-dose aspirin on acute inflammatory responses in humans. J Immunol 2009; 183: 2089-96.
5. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004; 94: 119-26.
6. Maglio D, Nightingale CH, Nicolau DP. Production and resolution of cantharidin-induced inflammatory blisters. Int J Antimicrob Agents 2003; 22: 77-80.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
8. Rebuck JW, Crowley JH. A method of studying leukocytic functions in vivo. Ann NY Acad Sci 1955; 59: 757-805.
9. Raeburn JA. A method for studying antibiotic concentrations in inflammatory exudate. J Clin Pathol 1971; 24: 633-5.
10. Kiistala U, Mustakallio KK. In vivo separation of epidermis by production of suction blisters. Lancet 1964; 1: 1444-5.
11. Boggs DR, Athens JW, Haab OP, Raab SO, Cartwright GE, Wintrobe MM. Induced inflammatory exudates in normal man. A method designed to study the qualitative and quantitative cellular response to a pyogenic stimulus. Am J Pathol 1964; 44: 61-71.
12. Morris T, Stables M, Colville-Nash P, Newson J, Bellingan G, de Souza PM, Gilroy DW. Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc Natl Acad Sci USA 2010; 107: 8842-7.
13. Stazzone AM, Borgs P, Witte CL, Witte MH. Lymphangitis and refractory lymphedema after treatment with topical cantharidin. Arch Dermatol 1998; 134: 104-6.
14. Schleimer RP, Spahn JD, Covar R, Szefler SJ. Glucocorticoids. In: Middleton's Allergy Principles and Practice, eds Adkinson NF, Yunginger JW, Busse WW etal. Philadelphia: Mosby, 2003; 870-913.
15. Wong M, Ziring D, Korin Y, Desai S, Kim S, Lin J, Gjertson D, Braun J, Reed E, Singh RR. TNFα blockade in human diseases: mechanisms and future directions. Clin Immunol 2008; 126: 121-36.
16. Brunner M, Schmiedberger A, Schmid R, Jäger D, Piegler E, Eichler HG, Müller M. Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling. Br J Clin Pharmacol 1998; 46: 425-31.
17. Maglio D, Teng R, Thyrum PT, Nightingale CH, Nicolau DP. Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluid. Antimicrob Agents Chemother 2003; 47: 1771-3.
18. Harbord MW, Marks DJ, Forbes A, Bloom SL, Day RM, Segal AW. Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Aliment Pharmacol Ther 2006; 24: 651-60.